Document is current
Any future updates will be listed below
-
Authors
Vieta, Eduard
Montes, José Manuel
Iborra, Pedro
Mozos, Alfonso
Sáez, Cristina
Benabarre, Antonio
-
Funding
Funding for this research was provided by:
Centro de Investigación Biomédica en Red de Salud Mental
Instituto de Salud Carlos III
Bristol-Myers Squibb
Servier
Elan
Pfizer
Eli Lilly and Company
AstraZeneca
Bangladesh Forest Research Institute
Takeda Oncology
Roche
Dainippon Sumitomo Pharma
Otsuka Pharmaceutical
Bristol-Myers Squibb
Servier
Ministerio de Ciencia e Innovación
Sanofi
Allergan
H. Lundbeck A/S
Stanley Medical Research Institute
Shire
National Alliance for Research on Schizophrenia and Depression
Gedeon Richter
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Management of asenapine treatment in clinical practice: Recommendations from a panel of experts
Journal Title: Revista de Psiquiatría y Salud Mental (English Edition)
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rpsmen.2018.03.005
CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rpsm.2018.03.007
Content Type: article
Copyright: © 2018 SEP y SEPB. Published by Elsevier España, S.L.U. All rights reserved.
